Good day, and thank you for standing by. Welcome to the Origin Enterprises plc 2021 Preliminary results Conference Call. At this time, all participants are in listen-only mode. After the speaker presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star and one on your telephone keypad. I must advise you that this conference is being recorded today on 29th of September 2021. I would now like to hand the conference over to your first speaker today, Sean Coyle. Please go ahead. Thank you, Yola, and welcome everybody. Good morning, and welcome to the Origin Enterprises 2021 preliminary results call. I'm joined here this morning by TJ Kelly, our Chief Financial Officer, and Brendan Corcoran, our Head of Investor Relations. I'm delighted to report this morning a strong recovery in profit from what has been a challenging 2020 year. I think we've made progress on a number of fronts, from a strategic perspective as well, showing underlying growth in a number of areas right across the business, strengthening the balance sheet and also rolling out a number of strategic areas across the group. The normal safe harbor statement there in relation to forward-looking statements, if you could take note of that, please. A stronger performance across all three segments in the group. Earnings recovered substantially from a base of EUR 44 million in 2020 up to EUR 61 million this year, which represented a 38% increase in operating profit. Margin expanded by 90 basis points to 3.7%. Our net bank debt position came in substantially lower at EUR 14.4 million. We continued to work on strengthening the balance sheet following what was a challenging 2020 year. We're delighted to announce this morning that we are resuming the payment of our final year dividend. The total dividend will be EUR 0.11, which represents a 37.3% payout of profit after tax. All of the individual segments across the group saw significant underlying growth. The most substantial of that was in the Ireland, U.K. segment at just north of 64%. Our continental European businesses saw underlying growth at 21.6%. Our Latin American businesses saw underlying growth of almost 17%. We're really pleased with the significant progress that all of the divisions have made. As I mentioned at the outset, the group continues to make progress in a number of areas. In particular, we're embedding the ESG agenda and sustainability into the organization and looking to get better strategic alignment across the group and collaboration and cooperation between the individual business units across the group. Maybe we'll touch on some of those. From an M&A perspective, what we saw in the year was the acquisition of Green-tech, which is a leading provider of products into the landscaping and the provision of services and products in particular into the urban renewal area. We think that's an important stepping stone for our Amenity business into new potential areas of growth. We also divested of our Belgian fertilizer business, Pillaert, during the year. As we said at the time, Pillaert has struggled to see any opportunity for consolidation within the market. We entered the market hoping to consolidate in the Belgian market but didn't find an appropriate opportunity to buy another player in that marketplace and have decided to divest and depart the market as a result of that. From a capital expenditure perspective, we've also invested in principally our Dynamics 365 ERP platform, which will replace our current Ireland and U.K. ERP platform and will be rolled out over the next 18 months across our Ireland, U.K. businesses. In addition to that then, we invested in a controlled release fertilizer plant in Brazil to expand our geographic reach for what our controlled release fertilizer, heavy tone, I suppose from a logistics capability perspective, fertilizers which need to be closer to market. Investing in that plant in Minas Gerais meant that we opened up a new segment of the market from a geographic perspective rather than the traditional Parana state where we have normally operated. We are embedding sustainability across the group, and in addition to the Green Horizons document which is our sustainability manifesto for the agri businesses, which was published last year. This year, we have announced the Fertile Future sustainability manifesto for our fertilizer businesses. We've seen continued improvement in our ESG ratings, and midway through October, we would expect to release Nurturing Growth, which will be our inaugural sustainability report on a standalone basis for the group. You'd expect to see more news on that later in the year. From an alignment perspective, obviously there's been a lot of work ongoing to bring the businesses closer together, we have progressed the Romanian merger and bringing our two separate businesses together under the Agrii brand over the last 12 months, and that has proved to be a success. We've also announced the integration of our Amenity businesses under one brand into the Origin Amenity Solutions brand in the U.K., and that work is ongoing. In addition to that then, we've done considerable work in rolling out our existing in-house products internally within the organization. We saw 44% growth of our in-house products across the European businesses, and we've now moved our in-house sales from about 12% of the BAM portfolio, biologicals, adjuvants, and micronutrients, up to about 16% of the BAM portfolio over the course of the last 12 months. That's been an important consideration for the business. Turning to the Ireland, U.K. segment, the business saw a strong recovery in profitability, albeit not as strong as the 2019 profit level we saw, and a delayed spring season, I suppose, curtailed some of the recovery in that respect. As we reported earlier in the year, there was a strong carryover of seed, in particular, on farm, and that restricted our seed sales in the first half of the year, and the delayed spring then restricted our crop protection sales to a certain extent. Our fertilizer businesses saw strong volume growth and return to growth, both from a margin and volume perspective. Our Amenity businesses also saw strong growth with good recovery following the easing of COVID-19 restrictions. Our feed joint venture businesses were challenged to a certain extent by the supply constraints, in particular, the challenges that we experienced in Argentina in relation to product departing Argentina and getting to the Irish marketplace, which left us in short supply for a period of time. On the whole, the business has performed reasonably well, and we're happy with the recovery and profitability of our Ireland, U.K. businesses. Our CE businesses also saw significant underlying growth. Operating profit at an underlying level grew by 21.6%. Revenue grew modestly at an underlying level, just under 6%, but shrunk at an overall level with pretty much all geographies seeing backwards movement in revenue. The focus that we've been talking about for the last couple of years of increasing the margin within the business by focusing on more strategic, higher margin products across the CE segment has come to fruition there. We're very happy with the performance of the business. Ukraine is probably the one cloudy spot in relation to the performance of the CE businesses. We did see a recovery back to a break-even level within the Ukrainian market, but we are disappointed that the profit level in the Ukrainian business was not as we would have wanted it to be, and it does remain quite a challenging market from a pricing perspective. From an overall perspective, very happy with the performance in Poland. Extremely happy with the performance in Romania, which has delivered despite all of the merger work that was going on there. We're happy that the Ukrainian performance has improved, but we still think we can do better in that marketplace. Within Latin America, again, underlying performance of this business was good. We saw very strong revenue growth, close to 60% at an underlying level, on the back of increased volumes and sales of our controlled-release fertilizer products, and that's been very strong. Our operating profit was up by almost 17% at an underlying level. Unfortunately, the continuing weakness of the Brazilian real has led to a translated profit coming in at a lower level than we would ordinarily have liked. EUR 6.3 million is down by 11% on the previous year's figure. At an underlying level, the Brazilian business continues to perform very well, and we're very happy with the operating performance of that business. Just as a reminder, the growth margin on controlled-release fertilizer products is typically about 50% of the gross margin available on the more traditional product range of biologicals, adjuvants, and micronutrients within that Latin American business. That's the principal reason for the dilution of margin year-on-year. I'll hand over to TJ now who'll talk through the financials. Thanks, Sean. Overall pleased to report strong set of financial metrics for our FY 2021. I'll focus on just some of them on this page. Looking to operating profit. As Sean mentioned earlier, a strong year of recovery. Operating profit increasing just over 38% to EUR 61 million, compared to EUR 44.1 million the previous year. That performance primarily driven by recovering volumes and margins in the U.K. and Ireland segment, which we'll cover in a little bit more detail later. EPS, similarly, has grown by just over 38% to EUR 0.355 Adjusted EPS, which is very much in line in the mid-range of the guidance that we gave at Q3 of EUR 0.34-EUR 0.36 Adjusted EPS. From a bank debt perspective and then again, I'll be very pleased with the further net bank debt reduction year-over-year. Closing net bank debt of EUR 14.4 million represents a circa EUR 39 million reduction in debt in comparing the two year-end positions. That really is reflective of continued strong cash generation across the group, driven by primarily the recovery in profitability in the year, continued strong focus on working capital, the benefit of the Pillaert disposal proceeds, and generally reduced CapEx across the business in the year as well. Just looking a little bit further then at working capital. Overall, we saw a modest outflow in the year of EUR 4 million compared to an inflow last year of EUR 30 million. Underlying, we continue to see significant progress in working capital reduction across our CE businesses. Really what happened to get to that net outflow position was that the later-than-usual seasonal volumes that we saw, particularly in the fertilizer business, really just pushed BioWave out that working capital to more Q4 than would typically be the case. That offsets effectively the underlying positives that we've seen come through in the CE levels of working capital. Overall, as I say, good progress been made and very pleased with the working capital reductions we've achieved. Dividends then, as Sean mentioned, again, pleased to announce the final dividend of EUR 0.0785, bringing the total dividend for the year to EUR 0.11, a payout of just over 37% of our profit after tax for our FY 2021. From a ROCE perspective, again, good progress up to 9.3% from 7.3% last year, again, driven by the improvement in profitability primarily, and also seeing the benefits of further reductions in average working capital levels, as I mentioned. From a revenue perspective, overall group revenue increased 6.2%. On an underlying basis, that was 8.4%. Within that, again, pleased with the progress that we've made in terms of volumes. Volume growth of 4.9%, largely fertilizer-led. We've seen growth in fertilizers of circa 4.8%. Chemicals are roughly the same, and seed volumes are back marginally in the year, as you'll be aware, due to the carryover of stock that we had from the previous year. Pricing growth of 3.5%. Again, largely fertilizer-led at just over 4%. Feed similarly saw price inflation during the year of just circa 4%, with feed pricing also up about 15% in the year. Moving to page 10. Maybe just draw your attention to a couple of the line items here. You'll notice that the finance costs have reduced by EUR 2.7 million to EUR 8.6 million in the year. Again, that's reflective of lower average debt levels in our business across the year. Not alone have we seen that strong year-on-year closing net debt position reduction, I suppose reflective really of the average position is that strong reduction in net interest costs in the year. Largely reflective of working capital progress and increase in profitability. The JV line, as Sean mentioned, back versus the prior year, largely driven by those supply chain issues that we've seen in our feed businesses. From a group revenue perspective, just to break out the EUR 105.6 million underlying revenue, that was largely driven, circa EUR 75 million of that EUR 105 coming through the U.K. and Ireland segment, really breaks out across the recovery in the Amenity business, post easing of lockdown restrictions, recovery in Agrii U.K. volumes, particularly in the last quarter of the year, strong fertilizer volume and pricing growth in the period. LATAM again, had a strong contribution. EUR 18 million of that EUR 105 was driven out of LATAM, reflecting, again, strong CRF volumes as we commissioned our new CRF plant in Minas Gerais, which went live in the second half of the year. The currency is primarily driven through the weakening of the Brazilian real against the Euro. From an OP perspective, that growth of EUR 18.6 million, again, is largely weighted towards the U.K. and Ireland. Agrii U.K. recovery, good volume performance in fertilizer, margin and volume performance in the fertilizer business has again been the key drivers. From a CE perspective, as Sean mentioned, overall the region recovered and delivered well in terms of OP growth. Brazil delivered a strong underlying profit growth, which unfortunately was eaten away by virtue of the translation impact, again, of that weakening Brazilian real to the Euro. From a Free Cash Flow perspective, again, as I said, the Free Cash Flow performance was strong. The year overall conversion as a percentage of PAT, just under 115%. As I mentioned, while there was an underlying outflow in working capital, we were pleased with the overall underlying performance in reduction in working capital. In absolute levels, particularly across the CE business. The CE business, for context, we have taken out about EUR 45 million of working capital over the last two years. Looking to our overall credit metrics, again, that strong cash performance has left us in a very strong position relative to covenants at the end of the year. We're also, again, pleased to announce that we've extended our banking facilities out to 2025. Over EUR 400 million banking facilities that we have extended, EUR 366 million of those now roll out to 2025, with EUR 34 million out to 2024. You'll also note that the pricing associated with the facilities is now linked to our sustainability ratings. With that, I'll hand it back to Sean. Thanks, TJ. In terms of the evolution of the business over time, obviously, the business has always had sustainable food production and soil health at its core. We continue to refine our offering and tailor our solutions to what is an ever-changing set of regulatory requirements. The regulatory environment for farming and for the, I suppose, business of agriculture and food production continues to change over time. As a result of that, we continue to change and, I suppose, refine our offering to focus more on sustainability. Within the Agri-inputs division, which is the left-hand side of the page, our fertilizer businesses and amenity businesses, the crop nutrition continue to develop new product sets and more sustainable products and solutions for growers. We're continuing to focus on proprietary value-added products within the product set which typically attract a higher margin for the group, and we continue to expand our in-house portfolio. From an M&A perspective, we'd like to continue to add to our in-house portfolio of specialty products within that. From an Amenity perspective, I think COVID in the last two years has taught us that social and health benefits related to green spaces and outdoor activities, and the longer-term move to, I suppose, boroughs and town councils and counties investing in green spaces and greenways continues to be a trend that we will see. If anything, hybrid working will continue to promote that type of activity. We see ourselves moving some of our activities into that area, albeit agriculture will very much be at the heart of what we do. We do see we have capability in that space from an Amenity perspective. We continue to add in new value-added technologies in the business, and we see the Amenity business as a one-shop stop which is serving several end markets. Within our agronomy businesses, on the right-hand side of the page, our Agri-services businesses, again, have always been involved in giving trusted advice on sustainable food production to all of our growers, whether that's in the arable sector or in the fruit and veg sector. The business has always had trusted advisors giving that best advice for sustainable food production. Increasing farm productivity and enhancing the environment can sit side by side with each other now. It's about getting an appropriate balance in that regard. A good example of that in the last 12 months has been the launch of our sustainable seed ratings within the Agri business, where we are giving advice on the best type of seed or best variety of seed in certain climatic conditions or certain soil types, and giving each of them a sustainable rating. We continue to develop the advice, continue to develop the product set, and tailor it for our customer base. Our digital agronomy platform continues to support and underpin that advice on farm. It will allow us to continue to give tailored advice at a sub-field level and develop climate-smart products that will facilitate sustainable practices. Whether it's identifying that part of the farm that is least productive and needs to be transitioned into ELMS schemes in the U.K., or identifying opportunities for variable rate application of fertilizer or variable rate application of seed. Essentially, the digital technology that we have supports that engagement with farmers and will allow us to deliver internal efficiencies and on-farm efficiencies for the farmer. I mentioned at the outset our Nurturing Growth standalone sustainability report, which we'd expect to publish at the same time as our annual report in the third week of October. What we set out within that is a framework for action over the next 10 years to align ourselves with I suppose the UN sustainability goals, Sustainable Development Goals, and a number of other areas where we feel that the business needs to improve. As we said earlier, we've published a Green Horizons charter and a Fertile Futures charter for both our Agri and fertilizer businesses, which is focused on the top right-hand side of that page there and the on-farm products and services that we're providing. We're also focused on a number of other areas, be it waste, water, climate change, operational excellence, and innovation. We have a number of initiatives and a framework for developing in a number of areas which we set out in that document. In addition to that, then we'll also focus on our society, our interaction with our customer base, our interaction with suppliers, and most importantly, our interaction with our own people. We set out within the document how we will engage with employees, our approach to diversity, equality, and inclusion, how we interact with the community. We did sign up to the UN Global Compact recently, that sets out our policies in relation to human rights, labor, the environment, and anti-corruption. There's a strong focus within the group on health, safety, and wellbeing. We're rolling out, for example, at the moment, a new health and safety software across the group to record and track incidents across the group. Essentially, it's important for us that all of our staff get home safely every evening. We're very focused on health, safety, and wellbeing across the group. In terms of growth in the business from a strategic perspective, we do continue to have very strong market positions in the global food production and Amenity sector, and we continue to focus on developing those and utilizing those strong market shares where we can. We're very much seen as a trusted advisor and input provider on farm with very long-term relationships, very long-term partnerships, both from a supplier perspective and from a customer perspective, and we intend to continue to leverage those. We have and continue to invest in collaborative research and technical innovation, transferring that new technology into commercial operations. Be it our CONSUS program, our investment in our digital platform, we continue to be at the forefront of developing new technologies. We see ourselves as being positioned to capitalize on evolving market trends. We are the leading advisor in terms of product capability and advice on farm, and see ourselves as being flexible in that regard in terms of how we interact with our customer base. Our M&A activity, in particular in the last 12 months, has continued to introduce a sustainability focus on what we buy from an M&A perspective. We will continue to have, I suppose, an ESG lens on the type of businesses that we buy within the group. We've always talked about expanding our proprietary products within the group, and we've always talked about seeking to expand our Amenity businesses from an M&A perspective. That hasn't changed, and the ESG lens will be brought to bear on those acquisitions as we grow. Specialty products, be it biologicals or micronutrients within our product set, will continue to be a focus. We're also looking at areas such as seed and fertilizer within that space but very much in the specialty area. Those segments of the market continue to grow at a faster rate than the general agriculture market that we are typically exposed to. They're growing typically at 7% to 10% per annum CAGR, so they are faster-growing segments of the market. Within our Amenity Solutions businesses, we're looking at areas that can be complementary to the agricultural landscape, such as forestry and landscaping, businesses such as seeds, the creation of new environments from an urban landscaping perspective, plant protection, and biologicals within that set. Our core was sports turf within that area. We're moving more into environmental services and urban landscaping with the acquisition of Green-tech, and potentially a subset of the garden products market could potentially be an area in which we'd have interest in expansion over the long term. We're delighted with the performance for 2021. It has given us, I suppose, a much strengthened balance sheet coming into 2022. The earnings and cash generation has led us to that position, and we're very happy to be reinstating the dividend as we exit the year. The acquisition of Green-tech has complemented our ambition to grow our offering of sustainable solutions within the group, and the business has had a good start to 2022. Things like seed sales across the U.K., which struggled because of the carryover on farm last year, are much improved year-on-year. Any of the challenges in relation to stock on farm that were experienced last year are no longer evident. There's certainly some evidence that the planted area of oilseed rape is up year-on-year. In geographies such as Romania, for example, which had experienced drought over the last couple of years, our start to the year has been quite strong because planting conditions have been pretty good due to rains which they've experienced over the last couple of months. Generally speaking, farmers are in a pretty good position from a balance sheet perspective. The high crop output prices that they have experienced in the last 12 months have allowed them to repair their balance sheet and improve the position on farm. Now, I would caution that high fertilizer prices going into next year will remain a challenge, and availability of raw materials, particularly from a fertilizer perspective, you'll have seen the news in relation to CF Industries and Yara and other producers of fertilizer raw materials, which will be a challenge over the coming 12 months. It's always difficult to predict the outcome for any fiscal year at this stage of the year. The start has been good to the year, and we need to keep an eye on some of the supply chain challenges that may be experienced over the coming 12 months. In general, we're reasonably happy with how the year has started, and we think that the business model is in good shape, and a lot of the strategic initiatives that we've been taking leave us well-placed to see further growth in 2022. With that, we'll hand over to questions, Yola, if you don't mind. We'll open the floor to questions. Thank you. Thank you. As a reminder, if you wish to ask a question, please press star and one on your telephone keypad as you wait for your name to be announced. If you wish to count your request please press the hash key. Once again, to ask a question, please you press star one on your telephone. Your first question comes from the line of Jason Meister. Good morning. Hi, good morning. Sean, you touched a bit on conditions in terms of the start to 2022. Can you maybe just delve a bit more on the U.K. side of things, soil conditions and obviously the recent weather that we've been seeing in the U.K., and how you think that feeds into the autumn-winter planting season? Second question is really around the dividend with the reintroduction this year. How should we think about that payment threshold going forward? Would be helpful. They're my two main questions. Thanks. Sure, Jason. I'll take the one on planting in the U.K., and maybe I'll let TJ take the question on dividends. U.K. harvest was delayed, I suppose, because of that cold spell during spring. Crop development was not necessarily as strong as it might have been and with a little bit of rain through August, which delayed harvest. That being said, conditions are reasonably good in the U.K., I would say, for planting at this point in time. As I mentioned earlier, the oilseed rape area seems to be up. We don't have final figures on that yet, but anecdotal evidence in the U.K. market is that there is more oilseed being planted in the U.K. this year versus previous years. Winter wheat planting will take place over probably the next six to eight weeks, and the reason that that goes into the ground a little bit later is for good agronomic practice reasons. Also, the delayed harvest has meant that there's a challenge in terms of turning around seed, getting it sent to seed dressing plants, getting it cleaned and back out on farm for drilling. There's plenty to happen over the next six to eight weeks from a winter wheat perspective. As it stands now, I would say the U.K. farmer is in reasonably good shape from a weather perspective, and they probably need at least a 10-day to two-week dry spell at some point in the next six to eight weeks just to get drilling done properly. Jason, on dividends, as I said, it appeared at just over 37%. Happy to be reintroducing at that level. I suppose, in terms of how to think about it, I would say, subject to earnings progression, we have stated our policy is to pay out greater than 35% PAT and to be a progressive payer. I think at this level, we would hope that we could be a progressive payer subject earnings. I guess that's always the caveat in this, right, is that we maintain earnings momentum and growth, and on the basis that we can, I think it's reasonable to think at EUR 0.11 as a reasonable base to build from into future years. As I say, the health warning is profile of earnings momentum out over those coming years. On the basis that that could happen, I think that is a reasonable assumption to make as we stand today, that EUR 0.11 is a base we can grow from. Okay, thanks very much. Another reminder, if you wish to ask a question, please press star one on your telephone. Your next question comes from the line of Kevin Fogarty from Numis. Hi. Good morning, guys. Thank you for the presentation this morning. I guess I have two questions really. One was really on product mix. We've clearly seen some impact of that during the last financial year. I just wondered if you could give us a view in terms of how that might progress going forward. Then just secondly, when you think about M&A, clearly there seems to be a shift, particularly you called out the Amenity space, and others. I just wondered sort of what you think competition looks like in those spaces, particularly kind of valuation multiples compared to what you paid previously? For sure. I suppose on the first question, product mix, the BAM portfolio, so biologicals, adjuvants, and micronutrients, typically represent about 10% of our crop protection sales. Then within that, our owned product, the proprietary businesses we own ourselves, represent about 16% of the total BAM portfolio. The total BAM portfolio grew by about 12% year-on-year last year. Our own product range grew by 45% or 44%. We do have ambition to grow that total portfolio number by certainly a high single-digit level again in the coming 12 months. The margin on BAM products is typically twice that of traditional crop chemistry or crop protection products. Yeah, product mix is important. It's probably incremental over time, Kevin, and replaces, I suppose, some of the margin that may be lost over time through products being revoked or the general pressures on the major R&D manufacturers from a price perspective. We see it as an opportunity to replace lost margin and perhaps add a small level or incrementally to margin. At an overall level, it's an important part of the group's growth and stability and earnings. From an M&A perspective, I think it depends on what we're buying, and it depends really on the growth rate of any asset that we might buy. You might find assets are growing by double-digit percentages or have net margins of 10%+, and clearly they'll be offered at multiples which will be higher than the traditional six to eight times multiple that we might have seen within the acquisitions of the past. There are assets still available at high single-digit multiples. We may see a mix of any acquisitions in that space between perhaps low double-digit multiples and high single-digit EBITDA multiples, depending on the type of asset that we buy. Okay, thanks very much. That is helpful. Thank you. We currently have no further questions. One last reminder, to ask a question, please press star and one on your telephone keypad. We have another question from the line of Jason Molins. Good morning. Yeah, hi. Sorry, just another question, if you don't mind. Sure. In terms of Brazil, you're expanding your offering with your CRF facility. Can you just talk a bit about the market there, your aspirations with what you're doing, finally wrapping that together in terms of the margin profile you mentioned, from an existing position versus the remainder of the Brazilian business? How should we think about that margin evolution as I guess that part of your portfolio increases? Thanks. Thanks, Jason. Yeah, our ambitions in relation to CRF are reasonably modest at this stage. I think the plant that we've built there is capable of producing something in the region of 25,000 to 30,000 tons of product per annum. We did about 12,000 tons last year of CRF product, we could potentially double our CRF business there over the next 12 months. We are seeing continued double-digit growth in the core product range, which is the biologicals, adjuvants, and micronutrients business. The margin differential between the two, typically CRF has about 50% of the gross margin level of our BAM portfolio. That's about a 50% gross margin in the BAM portfolio and about a 25% gross margin in the CRF portfolio. In terms of operating margin, we think that the business will retain a low double-digit percentage operating margin. I think we're looking at an operating margin at the moment in the region of 16%. It could settle down, depending on the mix of product, somewhere in the 12%-13% range over the next 12 months. Okay, that's helpful. Thanks. W e have another question from the line of Kevin Fogarty from Numis. Hi, guys. Just a quick sort of follow-up, if there's nobody else in the queue there. Sean, I guess sort of going back to your earlier piece, you mentioned sort of greater collaboration across the group. I just wondered if you'd shed a bit of light on what might that look like in terms of what could be done that perhaps hadn't been done in the past? How sort of close that integration or collaboration? Primarily, Kevin, it's in relation to the proprietary product sales intragroup and between business units across the group. That has yielded a 44% growth. Our Green-tech acquisition and our Agri businesses and our other Amenity businesses are also collaborating on opportunities across the group. Things like the wildflower seed mix, the John Chambers seed mix, which exists within the Green-tech business, should have an opportunity to be sold within Agri. There are other elements of the Green-tech product range which will be developed into a bespoke kind of environmental ELMs suite of products, and which can be delivered with Agri branding and Agri badging out to the farmer, despite the fact that it might be picked and packed in the Green-tech warehouses. That's ongoing. There are ongoing discussions between our Green-tech businesses and a number of the other Amenity businesses, the Origin Amenity Solutions business, which will allow further collaboration there into golf courses and other public facilities which are not traditionally in the landscaping space. We do see opportunity for continued collaboration across the group and even across our CE businesses and Agri. The way of working has continued to get closer together, so there are a number of pieces of work ongoing in relation to training and upskilling of staff, the production of technical materials for our CE businesses using our U.K. platform as a base. There's collaboration across the digital platforms as well. There's plenty of internal projects ongoing to keep us busy in relation to collaboration across the group. Sure. Okay, no, that's helpful. Thank you for that. We have no further questions. Okay. Please continue. Nothing else, Yola? No, we still have no further questions. All right. Okay, well, look, thank you very much, everybody, for joining the call this morning. We look forward to seeing you on the road or in person over the coming weeks. Thank you for joining the call this morning. Bye-bye. That does conclude our conference for today. Thank you for participating. You may all disconnect.